KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non Operating Investment Income: 2009-2011

Historic Non Operating Investment Income for Vertex Pharmaceuticals (VRTX) over the last 3 years, with Dec 2011 value amounting to -$16.8 million.

  • Vertex Pharmaceuticals' Non Operating Investment Income was N/A to $53.5 million in Q4 2013 from the same period last year, while for Dec 2013 it was $49.9 million, marking a year-over-year change of. This contributed to the annual value of -$16.8 million for FY2011, which is 59.25% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Non Operating Investment Income stood at -$16.8 million for FY2011, which was up 59.25% from -$41.2 million recorded in FY2010.
  • In the past 5 years, Vertex Pharmaceuticals' Non Operating Investment Income registered a high of -$1.8 million during FY2009, and its lowest value of -$41.2 million during FY2010.
  • Moreover, its 3-year median value for Non Operating Investment Income was -$16.8 million (2011), whereas its average is -$20.0 million.
  • Its Non Operating Investment Income has fluctuated over the past 5 years, first tumbled by 2,132.21% in 2010, then surged by 59.25% in 2011.
  • Vertex Pharmaceuticals' Non Operating Investment Income (Yearly) stood at -$1.8 million in 2009, then plummeted by 2,132.21% to -$41.2 million in 2010, then skyrocketed by 59.25% to -$16.8 million in 2011.